Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus: Why some tests fail

Arthritis and Rheumatism

Volumn 39, Issue 3, 1996, Pages 370-378

  Esdaile, John M ^a   Abrahamowicz, Michal ^a   Joseph, Lawrence ^a   MacKenzie, Todd ^a   Li, Yin ^a   Danoff, Deborah ^a  

^a MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; DNA; DNA ANTIBODY; DOUBLE STRANDED DNA;

ARTICLE; COMPLEMENT FIXATION; DISEASE ACTIVITY; DISEASE COURSE; DNA BINDING; ERYTHROCYTE SEDIMENTATION RATE; HEMATOCRIT; HUMAN; LABORATORY TEST; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE COUNT;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTINUCLEAR; BLOOD SEDIMENTATION; CHILD; COMPLEMENT C1Q; DATA INTERPRETATION, STATISTICAL; DNA; FEMALE; HEMATOCRIT; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; PLATELET COUNT; PREDICTIVE VALUE OF TESTS; RECURRENCE;

EID: 0029915745     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780390304     Document Type: Article

References (31)

1. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277, 1982
2. Harley JB, Gaither KK: Autoantibodies. Clin Rheum Dis 14: 43-56, 1988
3. Christian CL: Prognostic and therapeutic implications of immunologic test results in rheumatic disease. Hum Pathol 14:446-448, 1983
4. Bombardier C, Gladman DD, Urowitz MB, Karon D, Chang CH, and the Committee on Prognosis Studies in SLE: Derivation of SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 35:630-640, 1992
5. Urowitz MB, Gladman DD, Farewell VT, Stewart J, McDonald J: Lupus and pregnancy studies. Arthritis Rheum 36:1392-1397, 1993
6. Petri M, Genovese M, Engle E, Hochberg M: Definition, incidence, and clinical description of flare in systemic lupus erythematosus: a prospective cohort study. Arthritis Rheum 34:937-944, 1991
7. Liang MH, Socher SA, Larson MG, Schur PH: Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 32:1107-1118, 1989
8. Hay EM, Bacon PA, Gordon C, Isenberg DA, Maddison P, Snaith ML, Symmons DPM, Viner N, Zoma A: The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q J Med 86:447-458, 1993
9. Petri M, Hellmann D, Hochberg M: Validity and reliability of the lupus activity measures in the routine clinic setting. J Rheumatol 19:53-59, 1992
10. Gladman DD, Goldsmith CH, Urowitz MB, Bacon P, Bombardier C, Isenberg D, Kalunian K, Liang MH, Maddison P, Nived O, Richter M, Snaith M, Symmons D, Zoma A: Sensitivity to change of 3 systemic lupus erythematosus disease activity indices: international validation. J Rheumatol 21:1468-1471, 1994
11. Gladman DD, Goldsmith CH, Urowitz MB, Bacon P, Bombardier C, Isenberg D, Kalunian K, Liang MH, Maddison P, Nived O, Richter M, Snaith M, Symmons D, Zoma A: Crosscultural validation and reliability of 3 disease activity indices in systemic lupus erythematosus. J Rheumatol 19:608-611, 1992
12. Fleiss JL: Statistical Methods for Rates and Proportions. Second edition. New York, John Wiley and Sons, 1981
13. Waternaux C, Laird NM, Ware JH: Methods for analysis of longitudinal data: blood-lead concentrations and cognitive development. J Am Stat Assoc 84:33-41, 1989
14. Akaike H: A new look at the statistical model identification. IEEE Trans Automatic Control AC19:716-723, 1974
15. Sturfelt G, Jonsson N, Sjokolm AG: Sequential studies of complement activation in systemic lupus erythematosus. Scand J Rheumatol 14:184-196, 1985
16. Ter Borg EJ, Horst G, Limburg PC, Kallenberg CG: Changes in plasma levels of interleukin-2 receptor in relation to disease exacerbations and levels of anti-dsDNA and complement in systemic lupus erythematosus. Clin Exp Immunol 82:21-26, 1990
17. Ter Borg EJ, Horst G, Limburg PC, van Venrooij WJ, Kallenberg CG: Changes in levels of antibodies against the 70 kDa and A polypeptides of the U1RNP complex in relation to exacerbations of systemic lupus erythematosus. J Rheumatol 18:363-367, 1991
18. Ting CK, Hsieh KH: A long-term immunological study of childhood onset systemic lupus erythematosus. Ann Rheum Dis 51:45-51, 1992
19. Buyon JP, Tamerius J, Belmont HM, Abramson SB: Assessment of disease activity and impending flare in patients with systemic lupus erythematosus: comparison of the use of complement split products and conventional measurements of complement. Arthritis Rheum 35:1028-1037, 1992
20. Liang MH, Socher SA, Roberts WN, Esdaile JM: Measurement of systemic lupus erythematosus activity in clinical research. Arthritis Rheum 31:817-825, 1988
21. Holman HR: Thought barriers to understanding rheumatic diseases. Arthritis Rheum 37:1565-1567, 1994
22. Walz leBlanc BAE, Gladman DD, Urowitz MB: Serologically active clinical quiescent systemic lupus erythematosus: predictors of clinical flares. J Rheumatol 21:2239-2241, 1994
23. Swaak AJG, Groenwold J, Aarden LA, Statius van Eps LW, Feltkamp TEW: Prognostic value of anti-dsDNA in SLE. Ann Rheum Dis 41:388-395, 1982
24. Swaak AJG, Groenwold J, Bronsveld W: Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus. Ann Rheum Dis 45:359-366, 1986
25. Ter Borg EJ, Horst G, Hummel EJ, Limburg PC, Kallenberg CGM: Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus: a long-term, prospective study. Arthritis Rheum 33:634-643, 1990
26. Abrass CK, Nies KM, Louie JS, Border WA, Glassock RJ: Correlation and predictive accuracy of circulating immune complexes with disease activity in patients with systemic lupus erythematosus. Arthritis Rheum 23:273-282, 1980
27. Wallace DJ, Podell TE, Weiner JM, Cox MB, Klinenberg JR, Forouzesh S, Dubois EL: Lupus nephritis: experience with 230 patients in a private practice from 1950-1980. Am J Med 72:209-220, 1982
28. Appel GB, Cohen DJ, Pirani CL, Meltzer JI, Estes D: Long-term follow-up of patients with lupus nephritis: a study based on the classification of the World Health Organization. Am J Med 83:877-885, 1987
29. Laitman RS, Glicklich D, Sablay LB, Grayzel AI, Barland P, Bank N: Effect of long-term normalization of serum complement levels on the course of lupus nephritis. Am J Med 87: 132-138, 1989
30. Levey AS, Lan S-P, Corwin HL, Kasinath BS, Lachin J, Neilson EG, Hunsicker LG, Lewis EJ, and the Lupus Nephritis Collaborative Study Group: Progression and remission of renal disease in the Lupus Nephritis Collaborative Study: results of treatment with prednisone and short-term oral cyclophosphamide. Ann Intern Med 116:114-123, 1992
31. Fraenkel L, MacKenzie T, Joseph L, Kashgarian M, Hayslett JP, Esdaile JM: Response to treatment as a predictor of long-term outcome in patients with lupus nephritis. J Rheumatol 21:2052-2057, 1994